-
Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.
CancerClinical ResearchInnovationOncologyScientific Research -
Basel, Switzerland, December 16, 2019 – Novartis today announced topline results from its pivotal global Phase III LUSTER-11 and LUSTER-22 studies exploring the efficacy and safety of the investigational oral, once-daily, DP2 receptor antagonist fevipiprant (QAW039). The pooled analyses of the LUSTER trials did not meet3 the clinically relevant…RespiratoryClinical ResearchAd Hoc
-
Basel, April 22, 2020 — Data from the Phase III REACH2 study published today in The New England Journal of Medicine show Jakavi® (ruxolitinib) improves outcomes across a range of efficacy measures in patients with steroid-refractory acute graft-versus-host disease (GvHD) compared to best available therapy (BAT). The results of REACH2, the first…Reimagine MedicineInnovationClinical Research
-
Novartis researchers are working to extend the life of organ transplants
InnovationMedical InnovationsNovartis Institutes for BioMedical ResearchClinical ResearchClinical Trials -
Novartis investigators find genetic explanations for why some young patients relapse.
CancerCell and Gene TherapyNovartis Institutes for BioMedical ResearchClinical ResearchClinical Trials -
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
COVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug Development -
Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated.
Novartis Institutes for BioMedical ResearchClinical ResearchCareersClinical TrialsClinical Science -
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to HealthcareCancerCOVID-19OncologyWorking at NovartisClinical Research -
Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research
Drug DiscoveryGene SequencingNovartis Institutes for BioMedical ResearchClinical ResearchBiomedical JobsDrug Design -
Novartis taps MOOC technology to share chemistry education with the world
Drug DiscoveryNovartis Institutes for BioMedical ResearchTropical DiseasesClinical ResearchBiomedical JobsEye Disorders -
Experts call for significant changes to facilitate the discovery of new treatments.
Drug DiscoveryNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesClinical ResearchBiomedical Science -
Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
Novartis Institutes for BioMedical ResearchClinical ResearchClinical Trials
Pagination
- 1
- 2
- › Next page